Insights

Innovative Technology Cagent Vascular's proprietary Serration Technology in balloon angioplasty devices presents a unique value proposition for healthcare providers seeking advanced solutions for improved vessel dilation outcomes, opening opportunities for distribution and adoption.

Growing Market Focus The company's recent product launches targeting Chronic Limb-Threatening Ischemia and pedal disease indicate a strategic focus on high-need vascular conditions, suggesting potential sales channels in specialized endovascular clinics and hospital systems.

Strategic Partnerships Collaborations such as the recent partnership with 3comma Medical GmbH demonstrate an active engagement in expanding market reach and technology integration, providing avenues for joint ventures and co-marketing efforts.

Financial Backing Receiving $15 million in growth capital from Trinity Capital highlights strong investor confidence and resources available for scaling sales efforts and expanding product distribution networks globally.

Market Differentiation As the first and only company to commercialize serration-enabled angioplasty balloons, Cagent Vascular offers a distinctive product set that can appeal to major hospital chains, diagnostic centers, and private vascular specialists seeking innovative treatment options.

Cagent Vascular Tech Stack

Cagent Vascular uses 8 technology products and services including Hotjar, Tagembed, Cybot, and more. Explore Cagent Vascular's tech stack below.

Hotjar

Analytics

Tagembed

Content Management System

Cybot

Cookie Compliance

Salesforce

Customer Relationship Management

Google Fonts API

Font Scripts

Next.js

Javascript Frameworks

Swiper

Javascript Libraries

Cloudflare Bot Management

Security

Cagent Vascular Email Formats	Example	Percentage
FLast@cagentvascular.com	JDoe@cagentvascular.com	50%
FLast@cagentvascular.com	JDoe@cagentvascular.com	50%

Cagent Vascular Email Formats

Example

Percentage

FLast@cagentvascular.com

JDoe@cagentvascular.com

50%

FLast@cagentvascular.com

JDoe@cagentvascular.com

50%

Frequently Asked Questions

Where is Cagent Vascular's headquarters located?

Cagent Vascular's main headquarters is located at 150 Strafford Avenue, Suite 315 Wayne, PA 19087, US. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is Cagent Vascular's official website and social media links?

Cagent Vascular's official website is cagentvascular.com and has social profiles on LinkedIn Crunchbase.

What is Cagent Vascular's NAICS code?

Cagent Vascular's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Cagent Vascular have currently?

As of October 2025, Cagent Vascular has approximately 73 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Financial Officer: A. G.Vice President Of Sales: W. H.Vice President Operations: M. C.. Explore Cagent Vascular's employee directory with LeadIQ.

What industry does Cagent Vascular belong to?

Cagent Vascular operates in the Medical Equipment Manufacturing industry.

What technology does Cagent Vascular use?

Cagent Vascular's tech stack includes HotjarTagembedCybotSalesforceGoogle Fonts APINext.jsSwiperCloudflare Bot Management.

What is Cagent Vascular's email format?

Cagent Vascular's email format typically follows the pattern of FLast@cagentvascular.com. Find more Cagent Vascular email formats with LeadIQ.

How much funding has Cagent Vascular raised to date?

As of October 2025, Cagent Vascular has raised $9M in funding. The last funding round occurred on May 23, 2021 for $9M.

When was Cagent Vascular founded?

Cagent Vascular was founded in 2014.

Cagent Vascular

Q: What is Cagent Vascular's official website and social media links?

Cagent Vascular's official website is cagentvascular.com. Cagent Vascular has social profiles on LinkedIn.

Q: How many employees does Cagent Vascular have currently?

Cagent Vascular has approximately 73 employees.

Q: What technology does Cagent Vascular use?

Cagent Vascular's tech stack includes jQuery, Google Tag Manager, Google Cloud, Nginx, MySQL.

Medical Equipment ManufacturingUnited States51-200 Employees

Cagent Vascular is redefining balloon angioplasty with Serration Technology.

Headquartered in Wayne, PA, we are the first and only company to commercialize an angioplasty balloon featuring integrated serrations. Our mission is to elevate vessel preparation and treatment outcomes for patients with Peripheral Artery Disease (PAD) and Chronic Limb-Threatening Ischemia (CLTI).

Our flagship device, the Serranator® PTA Serration Balloon Catheter, is engineered to create controlled micro-serrations in the arterial wall. This mechanism of action delivers greater lumen gain and reduced recoil, critical for long-term success in endovascular interventions.

We believe it’s time for a new standard of care in angioplasty—and it begins with Serranator.

Insights

Similar companies to Cagent Vascular

Cook Medial

Penumbra

Cardinal Health

Medtronic

Inari Medical

Cagent Vascular Tech Stack

Media & News

Cagent Vascular, Inc. partnered with 3comma Medical GmbH on Apr 3rd '25.

Cagent Vascular, Inc. hired Paul Wilson as Chief Commercial Officer on Mar 4th '25.

Cagent Vascular, Inc. launches Balloon Catheter.

Cagent Vascular, Inc. receives financing of $15M in growth capital.

Trinity Capital Inc. invested into Cagent Vascular, Inc. $15M in growth capital on Feb 20th '25.

Cagent Vascular, Inc. launches Serranator SL-PRO percutaneous transluminal angioplasty serration balloon catheter for chronic limb-threatening ischaemia.

Cagent Vascular, Inc. launched Serranator SL-PRO PTA Serration Balloon Catheter on Feb 3rd '25.

Cagent Vascular's Email Address Formats